42 related articles for article (PubMed ID: 1718855)
21. Production, characterization and use of five monoclonal antibodies to human IL-4.
Scott MG; Levine AD; Butch AW; Bowen MB; Macke KA; Nahm MH
Lymphokine Res; 1990; 9(1):81-93. PubMed ID: 1691418
[TBL] [Abstract][Full Text] [Related]
22. Human interleukin-6 is in vivo an autocrine growth factor for human herpesvirus-8-infected malignant B lymphocytes.
Foussat A; Wijdenes J; Bouchet L; Gaidano G; Neipel F; Balabanian K; Galanaud P; Couderc J; Emilie D
Eur Cytokine Netw; 1999 Dec; 10(4):501-8. PubMed ID: 10586116
[TBL] [Abstract][Full Text] [Related]
23. Effects of PEGylation and immune complex formation on the pharmacokinetics and biodistribution of recombinant interleukin 10 in mice.
Alvarez HM; So OY; Hsieh S; Shinsky-Bjorde N; Ma H; Song Y; Pang Y; Marian M; Escandón E
Drug Metab Dispos; 2012 Feb; 40(2):360-73. PubMed ID: 22083830
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of humanized anti-interleukin-6 receptor antibody: antitumor activity in xenograft model of multiple myeloma.
Tsunenari T; Akamatsu K; Kaiho S; Sato K; Tsuchiya M; Koishihara Y; Kishimoto T; Ohsugi Y
Anticancer Res; 1996; 16(5A):2537-44. PubMed ID: 8917348
[TBL] [Abstract][Full Text] [Related]
25. The human bladder carcinoma line T-24 secretes a human B-cell differentiation factor.
Christie JF; Gallagher G; Stimson WH
Immunology; 1987 Mar; 60(3):467-9. PubMed ID: 3494671
[TBL] [Abstract][Full Text] [Related]
26. Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6.
Satoh T; Nakamura S; Taga T; Matsuda T; Hirano T; Kishimoto T; Kaziro Y
Mol Cell Biol; 1988 Aug; 8(8):3546-9. PubMed ID: 3264880
[TBL] [Abstract][Full Text] [Related]
27. IL-6/BSF-2 functions as a killer helper factor in the in vitro induction of cytotoxic T cells.
Okada M; Kitahara M; Kishimoto S; Matsuda T; Hirano T; Kishimoto T
J Immunol; 1988 Sep; 141(5):1543-9. PubMed ID: 3261754
[TBL] [Abstract][Full Text] [Related]
28. Establishment of an interleukin 6 (IL 6)/B cell stimulatory factor 2-dependent cell line and preparation of anti-IL 6 monoclonal antibodies.
Matsuda T; Hirano T; Kishimoto T
Eur J Immunol; 1988 Jun; 18(6):951-6. PubMed ID: 3260187
[TBL] [Abstract][Full Text] [Related]
29. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas.
Kawano M; Hirano T; Matsuda T; Taga T; Horii Y; Iwato K; Asaoku H; Tang B; Tanabe O; Tanaka H
Nature; 1988 Mar; 332(6159):83-5. PubMed ID: 3258060
[TBL] [Abstract][Full Text] [Related]
30. The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.
Muraguchi A; Hirano T; Tang B; Matsuda T; Horii Y; Nakajima K; Kishimoto T
J Exp Med; 1988 Feb; 167(2):332-44. PubMed ID: 3258006
[TBL] [Abstract][Full Text] [Related]
31. B cell stimulatory factor-2 is involved in the differentiation of cytotoxic T lymphocytes.
Takai Y; Wong GG; Clark SC; Burakoff SJ; Herrmann SH
J Immunol; 1988 Jan; 140(2):508-12. PubMed ID: 3257241
[TBL] [Abstract][Full Text] [Related]
32. Purification and NH2-terminal amino acid sequence of a T-cell-derived lymphokine with growth factor activity for B-cell hybridomas.
Van Snick J; Cayphas S; Vink A; Uyttenhove C; Coulie PG; Rubira MR; Simpson RJ
Proc Natl Acad Sci U S A; 1986 Dec; 83(24):9679-83. PubMed ID: 2948184
[TBL] [Abstract][Full Text] [Related]
33. Human interleukin 6 is a direct promoter of maturation of megakaryocytes in vitro.
Ishibashi T; Kimura H; Uchida T; Kariyone S; Friese P; Burstein SA
Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5953-7. PubMed ID: 2788282
[TBL] [Abstract][Full Text] [Related]
34. Designing CD4 immunoadhesins for AIDS therapy.
Capon DJ; Chamow SM; Mordenti J; Marsters SA; Gregory T; Mitsuya H; Byrn RA; Lucas C; Wurm FM; Groopman JE
Nature; 1989 Feb; 337(6207):525-31. PubMed ID: 2536900
[TBL] [Abstract][Full Text] [Related]
35. Recombinant human interleukin 6 (B cell stimulatory factor 2) enhances immunoglobulin secretion by single murine hapten-specific B cells in the absence of cell division.
Alderson MR; Pike BL
Int Immunol; 1989; 1(1):20-8. PubMed ID: 2487674
[TBL] [Abstract][Full Text] [Related]
36. IL-6 modulates the synthesis of a specific set of acute phase plasma proteins in vivo.
Marinkovic S; Jahreis GP; Wong GG; Baumann H
J Immunol; 1989 Feb; 142(3):808-12. PubMed ID: 2464026
[TBL] [Abstract][Full Text] [Related]
37. Human recombinant IL-6/B cell stimulatory factor 2 augments murine antigen-specific antibody responses in vitro and in vivo.
Takatsuki F; Okano A; Suzuki C; Chieda R; Takahara Y; Hirano T; Kishimoto T; Hamuro J; Akiyama Y
J Immunol; 1988 Nov; 141(9):3072-7. PubMed ID: 2459240
[TBL] [Abstract][Full Text] [Related]
38. Induction of rat acute-phase proteins by interleukin 6 in vivo.
Geiger T; Andus T; Klapproth J; Hirano T; Kishimoto T; Heinrich PC
Eur J Immunol; 1988 May; 18(5):717-21. PubMed ID: 2454191
[TBL] [Abstract][Full Text] [Related]
39. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2).
Hirano T; Taga T; Nakano N; Yasukawa K; Kashiwamura S; Shimizu K; Nakajima K; Pyun KH; Kishimoto T
Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5490-4. PubMed ID: 2410927
[TBL] [Abstract][Full Text] [Related]
40. Immunologic abnormality in NZB/W F1 mice. Thymus-independent expansion of B cells responding to interleukin-6.
Mihara M; Fukui H; Koishihara Y; Saito M; Ohsugi Y
Clin Exp Immunol; 1990 Dec; 82(3):533-7. PubMed ID: 2265491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
